Fry L - Search Results

1

The gut microbiome and primary open angle glaucoma: Evidence for a 'gut-glaucoma' axis?

Krilis M, Fry L, Ngo P, Goldberg I. Krilis M, et al. Among authors: fry l. Eur J Ophthalmol. 2024 Jul;34(4):924-930. doi: 10.1177/11206721231219147. Epub 2023 Dec 12. Eur J Ophthalmol. 2024. PMID: 38086752 Review.

2

Refractive Outcomes of the Yamane Flanged Intrascleral Haptic Fixation Technique.

Rocke JR, McGuinness MB, Atkins WK, Fry LE, Kane JX, Fabinyi DCA, Yeoh J, Chiu D, Essex MBiostat RW, Roufail E, Sheridan AM, Allen PJ, Edwards TL. Rocke JR, et al. Among authors: fry le. Ophthalmology. 2020 Oct;127(10):1429-1431. doi: 10.1016/j.ophtha.2020.03.032. Epub 2020 Apr 3. Ophthalmology. 2020. PMID: 32359838 Review. No abstract available.

3

Analysis of Pathogenic Variants Correctable With CRISPR Base Editing Among Patients With Recessive Inherited Retinal Degeneration.

Fry LE, McClements ME, MacLaren RE. Fry LE, et al. JAMA Ophthalmol. 2021 Mar 1;139(3):319-328. doi: 10.1001/jamaophthalmol.2020.6418. JAMA Ophthalmol. 2021. PMID: 33507217 Free PMC article.

4

Association of Messenger RNA Level With Phenotype in Patients With Choroideremia: Potential Implications for Gene Therapy Dose.

Fry LE, Patrício MI, Williams J, Aylward JW, Hewitt H, Clouston P, Xue K, Barnard AR, MacLaren RE. Fry LE, et al. JAMA Ophthalmol. 2020 Feb 1;138(2):128-135. doi: 10.1001/jamaophthalmol.2019.5071. JAMA Ophthalmol. 2020. PMID: 31855248 Free PMC article.

5

The coma in glaucoma: Retinal ganglion cell dysfunction and recovery.

Fry LE, Fahy E, Chrysostomou V, Hui F, Tang J, van Wijngaarden P, Petrou S, Crowston JG. Fry LE, et al. Prog Retin Eye Res. 2018 Jul;65:77-92. doi: 10.1016/j.preteyeres.2018.04.001. Epub 2018 Apr 6. Prog Retin Eye Res. 2018. PMID: 29631042 Review.

6

CRISPR genome engineering for retinal diseases.

Kantor A, McClements ME, Peddle CF, Fry LE, Salman A, Cehajic-Kapetanovic J, Xue K, MacLaren RE. Kantor A, et al. Prog Mol Biol Transl Sci. 2021;182:29-79. doi: 10.1016/bs.pmbts.2021.01.024. Epub 2021 Mar 19. Prog Mol Biol Transl Sci. 2021. PMID: 34175046

7

CRISPR Interference-Potential Application in Retinal Disease.

Peddle CF, Fry LE, McClements ME, MacLaren RE. Peddle CF, et al. Int J Mol Sci. 2020 Mar 27;21(7):2329. doi: 10.3390/ijms21072329. Int J Mol Sci. 2020. PMID: 32230903 Free PMC article. Review.

8

Expression of Rab Prenylation Pathway Genes and Relation to Disease Progression in Choroideremia.

Fry LE, Patrício MI, Jolly JK, Xue K, MacLaren RE. Fry LE, et al. Transl Vis Sci Technol. 2021 Jul 1;10(8):12. doi: 10.1167/tvst.10.8.12. Transl Vis Sci Technol. 2021. PMID: 34254989 Free PMC article.

9

Is subretinal AAV gene replacement still the only viable treatment option for choroideremia?

Han RC, Fry LE, Kantor A, McClements ME, Xue K, MacLaren RE. Han RC, et al. Expert Opin Orphan Drugs. 2021;9(1):13-24. doi: 10.1080/21678707.2021.1882300. Epub 2021 Mar 24. Expert Opin Orphan Drugs. 2021. PMID: 34040899 Free PMC article.

10

RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences.

Fry LE, Peddle CF, Barnard AR, McClements ME, MacLaren RE. Fry LE, et al. Int J Mol Sci. 2020 Jan 25;21(3):777. doi: 10.3390/ijms21030777. Int J Mol Sci. 2020. PMID: 31991730 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

547 results

Search Page

Filters